# CovDocker: Benchmarking Covalent Drug Design with Tasks, Datasets, and Solutions

arXiv: https://arxiv.org/abs/2506.21085 · HTML: https://mlsanity.com/paper/2506.21085/

## Key facts

- No citing papers in the map yet (data through 14 Oct 2026).
- Builds on 8 of its 66 references that are in the map.
- First posted on arXiv 26 Jun 2025.

## Builds on (most cited first, 8 of 8)

- [Adam: A Method for Stochastic Optimization](https://mlsanity.com/paper/1412.6980/) (2014)
- [Exploring the Limits of Transfer Learning with a Unified Text-to-Text Transformer](https://mlsanity.com/paper/1910.10683/) (2019)
- [DiffDock: Diffusion Steps, Twists, and Turns for Molecular Docking](https://mlsanity.com/paper/2210.01776/) (2022)
- [Professor Forcing: A New Algorithm for Training Recurrent Networks](https://mlsanity.com/paper/1610.09038/) (2016)
- [EquiBind: Geometric Deep Learning for Drug Binding Structure Prediction](https://mlsanity.com/paper/2202.05146/) (2022)
- [ReactionT5: a large-scale pre-trained model towards application of limited reaction data](https://mlsanity.com/paper/2311.06708/) (2023)
- [FABind+: Enhancing Molecular Docking through Improved Pocket Prediction and Pose Generation](https://mlsanity.com/paper/2403.20261/) (2024)
- [PoseX: AI Defeats Physics Approaches on Protein-Ligand Cross Docking](https://mlsanity.com/paper/2505.01700/) (2025)

## Abstract (arXiv)

Molecular docking plays a crucial role in predicting the binding mode of ligands to target proteins, and covalent interactions, which involve the formation of a covalent bond between the ligand and the target, are particularly valuable due to their strong, enduring binding nature. However, most existing docking methods and deep learning approaches hardly account for the formation of covalent bonds and the associated structural changes. To address this gap, we introduce a comprehensive benchmark for covalent docking, CovDocker, which is designed to better capture the complexities of covalent binding. We decompose the covalent docking process into three main tasks: reactive location prediction, covalent reaction prediction, and covalent docking. By adapting state-of-the-art models, such as Uni-Mol and Chemformer, we establish baseline performances and demonstrate the effectiveness of the benchmark in accurately predicting interaction sites and modeling the molecular transformations involved in covalent binding. These results confirm the role of the benchmark as a rigorous framework for advancing research in covalent drug design. It underscores the potential of data-driven approaches to accelerate the discovery of selective covalent inhibitors and addresses critical challenges in therapeutic development.
